Cargando…
Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens
Effective adoptive immunotherapy has proved elusive for many types of human cancer, often due to difficulties achieving robust expansion of natural tumor-specific T-cells from peripheral blood. We hypothesized that antigen-driven T-cell expansion might best be triggered in vitro by acute activation...
Autores principales: | Pathangey, Latha B., McCurry, Dustin B., Gendler, Sandra J., Dominguez, Ana L., Gorman, Jessica E., Pathangey, Girish, Mihalik, Laurie A., Dang, Yushe, Disis, Mary L., Cohen, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355224/ https://www.ncbi.nlm.nih.gov/pubmed/27974697 http://dx.doi.org/10.18632/oncotarget.13911 |
Ejemplares similares
-
Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes
por: Pathangey, Latha B., et al.
Publicado: (2016) -
MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
por: Lakshminarayanan, Vani, et al.
Publicado: (2016) -
Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis
por: Ben Baruch, Bar, et al.
Publicado: (2018) -
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells
por: Basu, Gargi D, et al.
Publicado: (2005) -
Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies
por: Müller, Fabian, et al.
Publicado: (2017)